NCT00099749

Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant

Official Title:

Safety and Efficacy of FTY720 in Adult Patients Who Receive a Kidney Transplant

Summary

The efficacy and safety of FTY720 is being evaluated in patients who receive a kidney transplant.

Eligibility

Inclusion Criteria:

* Male and Female
* Between 18 to 65 years old

Exclusion Criteria:

* Patients in need of multiple organ transplants

Disease(s) and\or Condition(s)

Kidney Transplantation

Primary Purpose
  • TREATMENT
Intervention/Treatment
    • Type: DRUG
    • Name: FTY 720
    • Description:
    • Arm Group Labels:
Sponsor
  • Novartis Pharmaceuticals